# The Blood Center – FDA Inspection, Jun 29, 2017

Source: https://www.keypedia.com/records/fda_inspections/the-blood-center/14e3bb82-1877-4b65-87df-b1e08f1ddf5f
Source feed: FDA_Inspections

> FDA inspection 1016227 of The Blood Center, June 29, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 606. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1016227
- Company Name: The Blood Center
- Inspection Date: 2017-06-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1229822 - 2024-08-16
- FDA Inspection 1172118 - 2022-06-17
- [FDA Inspection 1088614 - 2019-04-17](https://www.keypedia.com/records/fda_inspections/the-blood-center/d8eb2110-1790-4e68-b7c6-5f6c51f8931b)
- FDA Inspection 935002 - 2015-07-16
- FDA Inspection 907001 - 2014-12-11

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/abby-l-mozeke/ce4ecbbc-0108-483e-aff3-d5320e50114f)
- [FDA Associated Person](https://www.keypedia.com/people/cody-d-rickman/54deec25-dc65-4402-991a-ad5589bad78b)

Company: https://www.keypedia.com/companies/the-blood-center/bde0336d-65d1-4d3d-a045-4dfbe21bf116

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
